Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States

Nature Medicine

Volumn 9, Issue 4, 2003, Pages 424-430

  McCormick, Althea W ^a   Whitney, Cynthia G ^b   Farley, Monica M ^c   Lynfield, Ruth ^d   Harrison, Lee H ^e   Bennett, Nancy M ^f   Schaffner, William ^g   Reingold, Arthur ^h   Hadler, James ⁱ   Cieslak, Paul ^j   Samore, Matthew H ^k   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MINNESOTA DEPARTMENT OF HEALTH   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f Monroe County Department of Public Health   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CDC   (United States)

^j Office of Disease Prevention and Epidemiology   (United States)

^k UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PENICILLIN G; VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NONHUMAN; PENICILLIN RESISTANCE; PREDICTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

DRUG RESISTANCE; ERYTHROMYCIN; GEOGRAPHY; MATHEMATICS; MODELS, THEORETICAL; PENICILLIN RESISTANCE; SELECTION (GENETICS); STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; UNITED STATES;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0345668474     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm839     Document Type: Article

References (28)

1. Hausdorff, W.P., Bryant, J., Paradiso, P.R. & Siber, G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30, 100-121 (2000).
2. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 46, 1-24 (1997).
3. Baquero, F. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microb. Drug Resist. 1, 115-20 (1995).
4. Whitney, C.G. et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343, 1917-1924 (2000).
5. Geographic variation in penicillin resistance in Streptococcus pneumoniae-selected sites, United States, 1997. MMWR Morb. Mortal Wkly Rep. 48, 656-661 (1999).
6. Hyde, T.B. et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286, 1857-1862 (2001).
7. Garcia-Rey, C., Aguilar, L., Baquero, F., Casal, J. & Dal-Re, R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 40, 159-164 (2002).
8. Diekema, D.J., Brueggemann, A.B. & Doern, G.V. Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. Emerg. Infect. Dis. 6, 552-556 (2000).
9. Doern, G. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin. Infect. Dis. 33 (suppl. 3), 5187-5192 (2001).
10. Jones, M. Relationship between antibiotic resistance in Streptococcus pneumoniae and that in Haemophilus influenzae: evidence for common selective pressure. Antimicrob. Agents Chemother. 46, 3106-3107 (2002).
11. McEllistrem, M. et al. Distribution of penicillin-nonsusceptible pneumococcal clones in the Baltimore metropolitan area and variables associated with drug resistance. Clin. Infect. Dis. 34, 704-707 (2002).
12. Scott, J.A. et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin. Infect. Dis. 27, 1442-1450 (1998).
13. Fenoll, A., Jado, I., Vicioso, D., Perez, A., & Casal, J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J. Clin. Microbiol. 36, 3447-3454 (1998).
14. Pihlajamaki, M. et al. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin. Infect. Dis. 33, 483-488 (2001).
15. Arason, V.A. et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 313, 387-391 (1996).
16. de Neeling, A.J., Overbeek, B.P., Horrevorts, A.M., Ligtvoet, E.E. & Goettsch, W.G. Antibiotic use and resistance of Streptococcus pneumoniae in the Netherlands during the period 1994-1999. J. Antimicrob. Chemother. 48, 441-444 (2001).
17. Schuchat, A. et al. Active Bacterial Core surveillance of the Emerging Infections Program Network. Emerg, Infect. Dis. 7, 92-99 (2001).
18. McGee, L. et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J. Clin. Microbiol. 39, 2565-2571 (2001).
19. Black, S. et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19, 187-195 (2000).
20. Schrag, S.J., Beall, B. & Dowell, S.F. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin. Microbiol. Rev. 13, 588-601 (2000).
21. Lipsitch, M. The rise and fall of antimicrobial resistance. Trends Microbiol. 9, 438-444 (2001).
22. Lipsitch, M. Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes. Am. J. Epidemiol. 154, 85-92 (2001).
23. Andersson, D.I. & Levin, B.R. The biological cost of antibiotic resistance. Curr. Opin. Microbial. 2, 489-493 (1999).
24. National Ambulatory Medical Care Survey: 1993-1999 Summary. (National Center for Health Statistics, Centers for Disease Control and Prevention Hyattsville, Maryland, 2001).
25. National Hospital Ambulatory Medical Care Survey: 1993-1999 Outpatient Department Summary. (National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, 2001).
26. National Hospital Ambulatory Medical Care Survey: 1993-1999 Emergency Department Summary (National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, 2001).
27. Robinson, K.A. et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 285, 1729-1735 (2001).
28. Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard NCCLS Document M7-A5 (National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, 2000).